Serum Müllerian Inhibiting Substance/Anti-Müllerian Hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology
- 1 July 2009
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 114 (1) , 57-60
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Anti-Mullerian hormone and ovarian cancerHuman Reproduction Update, 2007
- High GATA-4 Expression Associates with Aggressive Behavior, whereas Low Anti-Müllerian Hormone Expression Associates with Growth Potential of Ovarian Granulosa Cell TumorsThe Journal of Clinical Endocrinology & Metabolism, 2005
- Granulosa Cell Tumor of the OvaryJournal of Clinical Oncology, 2003
- Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic ApplicationsEndocrine Reviews, 2001
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell TumorsGynecologic Oncology, 1999
- Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiolAmerican Journal of Obstetrics and Gynecology, 1996
- Mullerian inhibiting substance in humans: normal levels from infancy to adulthoodThe Journal of Clinical Endocrinology & Metabolism, 1996
- Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord TumorNew England Journal of Medicine, 1992
- The Ontogeny of Mullerian Inhibiting Substance in Granulosa Cells of the Bovine Ovarian FollicleBiology of Reproduction, 1986